glp-1 medications nutrient deficiency effects Dietary intake by patients taking and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs Nutritional priorities to support GLP-1

C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones

If you're unsure and can't reach a pharmacist, our AI doctor can help you figure out your next step

It contains semaglutide, a GLP-1 receptor agonist, similar to Ozempic and Wegovy but in a pill form

This did not present a risk in the researchers sample because they excluded people with body-mass indices (BMIs) lower than 23 (the World Health Organization considers BMIs 18.5 24.9 normal), and most study participants had a BMI of 30 or more (classified as obese)